References for Hepatitis B and C: An Overview

1. Thung SN, Shim K-S, Shieh YS, Schwartz M, Theise N, Borcich A, et al. Hepatitis C in liver allografts. Arch Pathol Lab Med 1993;117:145-149[ [ Link previously at www.ncbi.nlm.nih.gov ]].

2. Demetris AJ, Jaffe R, Sheahan DG, Burnham J, Spero J, Iwatsuki S, et al. Recurrent hepatitis B in liver allograft recipients. Am J Pathol 1986;125:161-172[ [ Link previously at www.ncbi.nlm.nih.gov ]].

3. Davies SE, Portmann BC, O’Grady JG, Aldis PM, Chaggar K, Alexander G, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991;13:150-157[ Abstract].

4. Thung SN, Gerber MA. Acute hepatitis versus cellular (acute) liver allograft rejection (chap 37). Cellular (acute) liver allograft rejection versus chronic liver allograft rejection (chap 39). In: Epstein JI (ed). Differential diagnosis in pathology liver disorders. New York: Igaku-Shoin Medical Publishers, Inc., 1995:38-39.

5. Thung SN, Gerber MA. Cellular (acute) liver allograft rejection versus chronic liver allograft rejection (chap 39). Chronic hepatitis in liver allografts versus chronic rejection (chap 43). In: Epstein JI (ed). Differential diagnosis in pathology liver disorders. New York: Igaku-Shoin Medical Publishers, Inc., 1995:42-43.

6. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou J-P, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993;329:1842-1847[ [ Link previously at www.ncbi.nlm.nih.gov ]].

7. Tur-Kaspa R, Laub O. Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system. J Hepatol 1990;11:34-36[ Medline].

8. McDiarmid SV, Farmer DA, Goldstein LI, Martin P, Vargas J, Tipton JR, et al. A randomized prospective trial of steroid withdrawal after liver transplantation. Transplantation 1995;60:1443-1450[ [ Link previously at www.ncbi.nlm.nih.gov ]].

9. De Man RA, Heijtink RA, Niesters HGM, Schalm SW. New developments in antiviral therapy for chronic hepatitis B infection. Scand J Gastroenterol 1995;212:100-104.

10. Marcellin P, Samuel D, Areias J, Gigou M, Benhamou JP, Bismuth H. Effect of pre-transplant recombinant alpha interferon treatment on HBV reinfection in patients with cirrhosis B [abstract]. Hepatology 1991;14:71A.

11. McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996;61:1358-1364[ [ Link previously at www.ncbi.nlm.nih.gov ]].

12. Shouval D, Ilan Y. Transplantation of hepatitis B immune lymphocytes as means for adoptive transfer of immunity to hepatitis B virus. J Hepatol 1995;23:98-101[ [ Link previously at www.ncbi.nlm.nih.gov ]].

13. Gretch DR, Bacchi CE, Corey L, DeLa Rosa C, Lesniewski RR, Kowdley K, et al. Persistent hepatitis C virus infection after liver transplantation: Clinical and virological features. Hepatology 1995;22:1-9[ Abstract].

14. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994;106:994-999[Abstract].

15. Schluger LK, Sheiner PA, Thung SN, Lau JYN, Min A, Wolf DC, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996;23:971-976[ Abstract].

16. Mueller AR, Platz K-P, Bechstein W-O, Blumhardt G, Lobeck H, Hop U, Neuhaus P. Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease. Transplant Proc 1994;26:3637-3639[ [ Link previously at www.ncbi.nlm.nih.gov ]].

17. Min AD, Bodenheimer HB. Does interferon precipitate rejection of liver allograft? Hepatology 1995;22:1333-1335[ [ Link previously at www.ncbi.nlm.nih.gov ]].

18. Wright HI, Gavaler JS, Van Thiel DH. Preliminary experience with -2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 1992;53:121-124[ [ Link previously at www.ncbi.nlm.nih.gov ]].

19. Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, et al. Interferon- therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994;20:773-779[ Abstract].

20. Féray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection. Hepatology 1995;22:1084-1089[ Abstract].

21. Vargas V, Charco R, Castells L, Esteban R, Margarit C. Alpha-interferon for acute hepatitis C in liver transplant patients. Transplant Proc 1995;27:1222-1223[ [ Link previously at www.ncbi.nlm.nih.gov ]].

22. Bodenheimer HC, Lindsay KL, Davis GL, Lewis JH, Thung SN, Seeff LB. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trial. Hepatology 1997;26:473-477[ Abstract].

23. Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997;26:500-504[ Abstract].

24. McHutchison JG. Ribavirin and interferon for recurrent posttransplantation HCV infection: To treat or not to treat? Hepatology 1997;26:505-506[ [ Link previously at www.ncbi.nlm.nih.gov ]].

25. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-322[Abstract].

26. Sheiner PA, Schluger LK, Emre S, Thung SN, Lau JYN, Guy SR, et al. Retransplantation for recurrent hepatitis C. Liver Transplant Surg 1997;3:130-136[Abstract].

Liver Transplantation and Surgery, Vol 4, No 5, Suppl 1 (September), 1998: pp S65-S67

1074-3022/98/0405-1009$3.00/0

Return To Article

Table Of Contents